Cardiovascular research · 2025
Coupling of USP10 de-ubiquitination and chaperone-mediated autophagy causes cardiac sodium channel degradation and cardiac arrhythmias.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiong Hongbo, Guo Di, Zhou Zhen, Xiang Lilin, Kong Xiangjie, Zhang Tong, Wang Zhijie, Cai Huanhuan, Fan Di, Wang Qiongxin, Du Yimei, Wang Qing K, Lu Zhibing
Аннотация
AIMS: SCN5A encodes cardiac sodium channel Nav1.5 that maintains normal electrophysiological functions of hearts. Loss-of-function variants of Nav1.5 reduce sodium current densities (INa) and cause arrhythmias such as cardiac conduction block or Brugada syndrome. The regulatory mechanisms of Nav1.5 functions are not fully understood. The aim of this study was to identify novel proteins that interact with Nav1.5 and characterize their regulatory mechanisms on Nav1.5 and arrhythmias.
METHODS AND RESULTS: GST pull-down coupled with mass spectrometry, co-immunoprecipitation, and mutational analysis were used to identify de-ubiquitinating enzyme USP10 as a novel Nav1.5-interacting protein, and showed that USP10 reduces Nav1.5 protein expression and INa densities in vitro. AAV9-mediated cardiac overexpression of USP10 in mice reduced Nav1.5 protein expression, INa and ICa-L densities, shortened APD, and caused delayed ventricular activation, spontaneous atrioventricular conduction block, sinus pause, and ventricular tachycardia induced with electrical pacing. Cardiac knockdown of USP10 in Scn5a+/- mice restored Nav1.5, INa, and ICa-L to levels comparable to wild-type mice, and alleviated the conduction delay and premature ventricular contractions. Mechanistically, USP10 increased Nav1.5 protein degradation through chaperone-mediated autophagy (CMA) as the effect was blocked by lysosome inhibitor CQ and inhibition of CMA using siRNA targeting LAMP2A or HSC70, but not by proteasomal inhibitor MG132. Mutational analysis identified the key CMA degradation motif of Nav1.5 as EKRFQ431-435. USP10 decreased Nav1.5 ubiquitination and increased binding of Nav1.5 to HSC70. Mutational analysis identified K430 of Nav1.5 as the USP10 de-ubiquitination site, and K430R mutation blocked regulation of Nav1.5 by USP10.
CONCLUSION: We identified a novel CMA-mediated pathway regulating degradation of Nav1.5 by coupling with USP10-mediated de-ubiquitination at K430 of Nav1.5, which resulted in reduced INa densities and cardiac conduction defects. Knockdown of USP10 alleviated arrhythmias in Scn5a+/- mice, providing a novel therapeutic strategy for treating arrhythmias with reduced INa.
METHODS AND RESULTS: GST pull-down coupled with mass spectrometry, co-immunoprecipitation, and mutational analysis were used to identify de-ubiquitinating enzyme USP10 as a novel Nav1.5-interacting protein, and showed that USP10 reduces Nav1.5 protein expression and INa densities in vitro. AAV9-mediated cardiac overexpression of USP10 in mice reduced Nav1.5 protein expression, INa and ICa-L densities, shortened APD, and caused delayed ventricular activation, spontaneous atrioventricular conduction block, sinus pause, and ventricular tachycardia induced with electrical pacing. Cardiac knockdown of USP10 in Scn5a+/- mice restored Nav1.5, INa, and ICa-L to levels comparable to wild-type mice, and alleviated the conduction delay and premature ventricular contractions. Mechanistically, USP10 increased Nav1.5 protein degradation through chaperone-mediated autophagy (CMA) as the effect was blocked by lysosome inhibitor CQ and inhibition of CMA using siRNA targeting LAMP2A or HSC70, but not by proteasomal inhibitor MG132. Mutational analysis identified the key CMA degradation motif of Nav1.5 as EKRFQ431-435. USP10 decreased Nav1.5 ubiquitination and increased binding of Nav1.5 to HSC70. Mutational analysis identified K430 of Nav1.5 as the USP10 de-ubiquitination site, and K430R mutation blocked regulation of Nav1.5 by USP10.
CONCLUSION: We identified a novel CMA-mediated pathway regulating degradation of Nav1.5 by coupling with USP10-mediated de-ubiquitination at K430 of Nav1.5, which resulted in reduced INa densities and cardiac conduction defects. Knockdown of USP10 alleviated arrhythmias in Scn5a+/- mice, providing a novel therapeutic strategy for treating arrhythmias with reduced INa.